H19 and chronic myelogenous leukemia, BCR-ABL1 positive: A similarpattern of H19 expression is observed in various types ofleukemia, including chronic myeloid leukemia (CML)(20, 21) and acute myeloid leukemia (AML) (22), as well.These observations together suggest dual roles for H19 asan oncogene or a tumor suppressor in various cancers (20).Therefore, future studies could evaluate the potential forlncRNAs as therapeutic targets or prognostic biomarkers incancer treatments (23).